Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection

Myasthenia gravis (MG) is an autoimmune neuromuscular transmission disorder characterized by loss of acetylcholine receptors (AChR’s) due primarily to the production of anti-AChR autoantibodies. In this study we investigated whether the presence of decay-accelerating factor (DAF or CD55), an intrins...

Celý popis

Podrobná bibliografie

Vydáno v:	J Clin Invest
Hlavní autoři:	Lin, Feng, Kaminski, Henry J., Conti-Fine, Bianca M., Wang, Wei, Richmonds, Chelliah, Medof, M. Edward
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Clinical Investigation 2002
Témata:	Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC151616/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12417565/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI16086
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!